Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

CRISPR Therapeutics, the biotech that co-developed the therapy, laid off about 50 employees. “Everyone was dumbfounded,” said a scientist who was let go. It was one early sign that ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

Using cutting-edge genome-editing techniques, including the CRISPR D-BUGS protocol ... with enhanced capabilities for biotechnology applications. "The synthetic yeast genome represents a quantum ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Using cutting-edge genome-editing techniques, including the CRISPR D-BUGS protocol ... with enhanced capabilities for biotechnology applications. "The synthetic yeast genome represents a quantum ...

In addition, first-generation CRISPR systems (Cas9 and Cas12a) are too large for efficient in vivo delivery via a single adeno-associated viral (AAV) vector. Now, new preclinical research ...

I am Debjit, one of the therapeutic analysts here, and joining me from CRISPR Therapeutics is CEO, Samarth Kulkarni. Thank you so much, Sam. Yeah. Happy to do that. I think we’ve been around as ...